The EAP is deeply saddened to announce the death of Jose Ramet.
Jose joined EAP (then CESP) in 1993 and was voted President the same year. Based in Brussels he was hugely influential in integrating the various groups of paediatricians responsible for primary, secondary and tertiary care. He developed links with specialist groups, bringing them in to work together under the single organization, and was critical in developing the integrated and harmonious paediatric group we are now lucky to enjoy.
In 1999, he gave up his post to become secretary-general. He contributed to the further development of relations with the American Academy of Pediatrics and was in charge of promoting the AAP Prep Programme in Europe. Over the last few years he has been troubled by significant ill health, but has continued to provide support and encouragement to the society.
Jose was a respectful gentleman that was able to combine knowledge, elegance and spirit in a unique attitude.
EAP gala dinners were cheered by the sagacious and brilliant speeches which he gave to entertain the EAP members while presenting also the visions and the achievements of EAP mission.
We will greatly miss his calm, supportive presence, his enthusiasm and his wise advice. He has been a huge presence in EAP, despite his illness over the last few years, and our thoughts are with his friends and family at this very sad time.
New ways to test high-risk medical devices.
Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.
It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.
